{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:06:06Z","timestamp":1794438366672,"version":"4.9.1"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7034a2","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T09:48:12Z","timestamp":1629971292000},"page":"1136-1141","source":"Crossref","is-referenced-by-count":105,"title":["Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines \u2014 38 States and the District of Columbia, 2019\u20132020"],"prefix":"10.15585","volume":"70","author":[{"given":"Stephen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Matt","family":"Gladden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londell","family":"McGlone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic.","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R2","doi-asserted-by":"publisher","first-page":"e198325","DOI":"10.1001\/jamanetworkopen.2019.8325","article-title":"Rates of physician coprescribing of opioids and benzodiazepines after the release of the Centers for Disease Control and Prevention Guidelines in 2016.","volume":"2","author":"Jeffery","year":"2019","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018.","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/add.14614","article-title":"How the complex pharmacology of the fentanyls contributes to their lethality.","volume":"114","author":"Gill","year":"2019","journal-title":"Addiction"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R5","doi-asserted-by":"publisher","first-page":"e210393","DOI":"10.1001\/jamahealthforum.2021.0393","article-title":"Trends in filled naloxone prescriptions before and during the COVID-19 pandemic in the United States.","volume":"2","author":"O\u2019Donoghue","year":"2021","journal-title":"JAMA Health Forum"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R6","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.fsisyn.2021.100138","article-title":"Benzodiazepines reported in NFLIS-Drug, 2015 to 2018.","volume":"3","author":"Bollinger","year":"2021","journal-title":"Forensic Sci Int Synerg"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R7","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.drugalcdep.2020.108486","article-title":"Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.","volume":"219","author":"Jones","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bky049","article-title":"The opioid epidemic: moving toward an integrated, holistic analytical response.","volume":"43","author":"Morrow","year":"2019","journal-title":"J Anal Toxicol"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.15585\/mmwr.mm7015a3","article-title":"Update: COVID-19 pandemic\u2013associated changes in emergency department visits\u2014United States, December 2020\u2013January 2021.","volume":"70","author":"Adjemian","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7034a2-202108260836-R10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ADM.0000000000000726","article-title":"Associations between polysubstance use patterns and receipt of medications for opioid use disorder among adults in treatment for opioid use disorder.","volume":"15","author":"Ford","year":"2021","journal-title":"J Addict Med"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T09:48:14Z","timestamp":1629971294000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7034a2.htm?s_cid=mm7034a2_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":10,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2021,8,27]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7034a2","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,27]]},"published":{"date-parts":[[2021,8,27]]}}}